Blog

by Amy DuRoss | July 22, 2019
In cell therapy, gene therapy, and personalized cancer vaccines, most media coverage understandably focuses on the medicine. But as the field of personalized therapeutics expands, a few authors are catching on to the fact that other innovations --…

by Marc Puich | July 10, 2019
Previously in this series, we discussed the Strategy, the Operational Ecosystem, and the Processes needed to establish an effective personalized medicine supply chain. Now, we’ll turn our attention to one more essential component -- managing risks…

by Amy DuRoss | July 1, 2019
Each year, the World Economic Forum welcomes leading early-stage companies from around the world into its Technology Pioneers community. Today, I’m both thrilled and humbled to share the news that Vineti has been named a global Technology Pioneer in…

by Amy DuRoss | June 26, 2019
At Vineti, we’re pushing every day to help the field of advanced therapies -- cell therapy, gene therapy, personalized cancer vaccines, and more -- grow. So we’re honored and humbled to be able to help in a whole new way, by joining the leadership of…

by Heidi Hagen | June 19, 2019
In cell therapy and gene therapy, in-process and final product labeling matters more to patient safety than ever before -- and it’s also more complex. We’ve been working with other industry leaders on new and updated standards for cell and gene…

Subscribe to our blog
Required
Required
Required
Required
Required
Required
Required
Required